Barings’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-8,600
Closed -$304K 1004
2015
Q1
$304K Sell
8,600
-18,100
-68% -$640K 0.01% 805
2014
Q4
$909K Sell
26,700
-27,665
-51% -$942K 0.02% 488
2014
Q3
$2.1M Sell
54,365
-30,335
-36% -$1.17M 0.05% 288
2014
Q2
$3.3M Buy
84,700
+54,200
+178% +$2.11M 0.1% 211
2014
Q1
$1.04M Buy
30,500
+1,800
+6% +$61.6K 0.03% 452
2013
Q4
$602K Buy
28,700
+8,700
+44% +$182K 0.03% 558
2013
Q3
$470K Sell
20,000
-3,800
-16% -$89.3K 0.02% 635
2013
Q2
$640K Buy
+23,800
New +$640K 0.03% 540